Novo Nordisk announced that Rybelsus, a once-a-day semaglutide pill, received a new Health Canada authorization, with all other GLP-1 drugs available in Canada to date being injectables
Dial 208-732-2020 today to arrange your initial consultation and make the first move towards a more vibrant and confident you
Lancet 2006;368:1696-705.ArticlePubMed 8
Lab values (glucose, cholesterol, triglycerides) often show measurable improvement by this point, which your provider tracks at follow-up visits
Retatrutide is an investigational GLP-1, GIP, and glucagon triple receptor agonist currently in Phase 3 trials
Melanotan-1 is fully cleared within 24 hours, so there is no pharmacokinetic reason to wait before starting a different peptide protocol